FIELD: medicine.
SUBSTANCE: invention relates to α4β7 integrin antagonist, which is dimer containing two compounds of the formula (I), covalently bound to each other, its pharmaceutical composition and a method for the treatment of a condition related to biological α4β7 integrin function.
EFFECT: obtaining α4β7 integrin antagonist.
22 cl, 9 dwg, 3 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF PEDIATRIC DISORDERS/DISEASES | 2018 |
|
RU2778567C2 |
| NOVEL DERIVATIVES OF PHENYLALANINE | 2001 |
|
RU2286340C2 |
| COMBINATION THERAPY WITH C-C CHEMOKINE RECEPTOR 9 (CCR9) INHIBITORS AND α4β7-INTEGRIN BLOCKING ANTIBODIES | 2015 |
|
RU2823984C2 |
| HUMANISED ANTI-BETA 7 ANTAGONISTIC ANTIBODIES AND USE THEREOF | 2005 |
|
RU2453558C2 |
| COMBINED THERAPY WITH INHIBITORS OF C-CHEMOKINE RECEPTOR 9 (CCR9) AND ANTIBODIES BLOCKING α4β7-INTEGRIN | 2015 |
|
RU2713653C2 |
| SULFONAMIDE DERIVATIVE AND MEDICINAL USE THEREOF | 2014 |
|
RU2667520C9 |
| DERIVATIVES OF THIOAMIDE AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2245874C2 |
| CYCLIC INHIBITORS OF ADHESION | 1997 |
|
RU2184121C2 |
| BOMBESIN ANALOGUE PEPTIDE ANTAGONIST CONJUGATES | 2009 |
|
RU2523531C2 |
| CYCLOPEPTIDES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD OF ITS PREPARING | 1996 |
|
RU2157379C2 |
